|
1
|
Singletary SE: Rating the risk factors for
breast cancer. Ann Surg. 237:474–482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Autiero M, Waltenberger J, Communi D,
Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M,
Bono F, et al: Role of PlGF in the intra- and intermolecular cross
talk between the VEGF receptors Flt1 and Flk1. Nat Med. 9:936–943.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou Y, Gunput RA and Pasterkamp RJ:
Semaphorin signaling: Progress made and promises ahead. Trends
Biochem Sci. 33:161–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perälä N, Sariola H and Immonen T: More
than nervous: The emerging roles of plexins. Differentiation.
83:77–91. 2012. View Article : Google Scholar
|
|
6
|
Tamagnone L, Artigiani S, Chen H, He Z,
Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, et al:
Plexins are a large family of receptors for transmembrane,
secreted, and GPI-anchored semaphorins in vertebrates. Cell.
99:71–80. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Regev A, Goldman S and Shalev E:
Semaphorin-4D (Sema-4D), the Plexin-B1 ligand, is involved in mouse
ovary follicular develop ment. Reprod Biol Endocrinol. 5:122007.
View Article : Google Scholar
|
|
8
|
Pasterkamp RJ and Giger RJ: Semaphorin
function in neural plasticity and disease. Curr Opin Neurobiol.
19:263–274. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizui M, Kumanogoh A and Kikutani H:
Immune semaphorins: Novel features of neural guidance molecules. J
Clin Immunol. 29:1–11. 2009. View Article : Google Scholar
|
|
10
|
Wray NR, James MR, Mah SP, Nelson M,
Andrews G, Sullivan PF, Montgomery GW, Birley AJ, Braun A and
Martin NG: Anxiety and comorbid measures associated with PLXNA2.
Arch Gen Psychiatry. 64:318–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fujii T, Uchiyama H, Yamamoto N, Hori H,
Tatsumi M, Ishikawa M, Arima K, Higuchi T and Kunugi H: Possible
association of the semaphorin 3D gene (SEMA3D) with schizophrenia.
J Psychiatr Res. 45:47–53. 2011. View Article : Google Scholar
|
|
12
|
Negishi-Koga T, Shinohara M, Komatsu N,
Bito H, Kodama T, Friedel RH and Takayanagi H: Suppression of bone
formation by osteoclastic expression of semaphorin 4D. Nat Med.
17:1473–1480. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hall KT, Boumsell L, Schultze JL,
Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM and
Freeman GJ: Human CD100, a novel leukocyte semaphorin that promotes
B-cell aggregation and differentiation. Proc Natl Acad Sci USA.
93:11780–11785. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishida I, Kumanogoh A, Suzuki K, Akahani
S, Noda K and Kikutani H: Involvement of CD100, a lymphocyte
semaphorin, in the activation of the human immune system via CD72:
Implications for the regulation of immune and inflammatory
responses. Int Immunol. 15:1027–1034. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deaglio S, Vaisitti T, Bergui L, Bonello
L, Horenstein AL, Tamagnone L, Boumsell L and Malavasi F: CD38 and
CD100 lead a network of surface receptors relaying positive signals
for B-CLL growth and survival. Blood. 105:3042–3050. 2005.
View Article : Google Scholar
|
|
16
|
Bougeret C, Mansur IG, Dastot H, Schmid M,
Mahouy G, Bensussan A and Boumsell L: Increased surface expression
of a newly identified 150-kDa dimer early after human T lymphocyte
activation. J Immunol. 148:318–323. 1992.PubMed/NCBI
|
|
17
|
Ch’ng ES and Kumanogoh A: Roles of Sema4D
and Plexin-B1 in tumor progression. Mol Cancer. 9:2512010.
View Article : Google Scholar
|
|
18
|
Nagase T, Ishikawa K, Nakajima D, Ohira M,
Seki N, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O:
Prediction of the coding sequences of unidentified human genes.
VII. The complete sequences of 100 new cDNA clones from brain which
can code for large proteins in vitro. DNA Res. 4:141–150. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang BS, Ahmad M, Deng AY and Leenen FH:
Neuronal responsiveness to central Na+ in 2 congenic
strains of Dahl saltsensitive rats. Hypertension. 49:1315–1320.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Artigiani S, Conrotto P, Fazzari P,
Gilestro GF, Barberis D, Giordano S, Comoglio PM and Tamagnone L:
Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep.
5:710–714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kato S, Kubota K, Shimamura T, Shinohara
Y, Kobayashi N, Watanabe S, Yoneda M, Inamori M, Nakamura F,
Ishiguro H, et al: Semaphorin 4D, a lymphocyte semaphorin, enhances
tumor cell motility through binding its receptor, plexinB1, in
pancreatic cancer. Cancer Sci. 102:2029–2037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ch’ng E, Tomita Y, Zhang B, He J, Hoshida
Y, Qiu Y, Morii E, Nakamichi I, Hamada K, Ueda T, et al: Prognostic
significance of CD100 expression in soft tissue sarcoma. Cancer.
110:164–172. 2007. View Article : Google Scholar
|
|
23
|
Sierra JR, Corso S, Caione L, Cepero V,
Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H,
Comoglio PM, et al: Tumor angiogenesis and progression are enhanced
by Sema4D produced by tumor-associated macrophages. J Exp Med.
205:1673–1685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gabrovska PN, Smith RA, Tiang T, Weinstein
SR, Haupt LM and Griffiths LR: Semaphorin-plexin signalling genes
associated with human breast tumourigenesis. Gene. 489:63–69. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Conrotto P, Corso S, Gamberini S, Comoglio
PM and Giordano S: Interplay between scatter factor receptors and B
plexins controls invasive growth. Oncogene. 23:5131–5137. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Conrotto P, Valdembri D, Corso S, Serini
G, Tamagnone L, Comoglio PM, Bussolino F and Giordano S: Sema4D
induces angiogenesis through Met recruitment by Plexin B1. Blood.
105:4321–4329. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wong OG, Nitkunan T, Oinuma I, Zhou C,
Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, et al:
Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci USA.
104:19040–19045. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiang R, Wang F, Shi LY, Liu M, Chen S,
Wan HY, Li YX, Li X, Gao SY, Sun BC, et al: Plexin-B1 is a target
of miR-214 in cervical cancer and promotes the growth and invasion
of HeLa cells. Int J Biochem Cell Biol. 43:632–641. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valente G, Nicotra G, Arrondini M, Castino
R, Capparuccia L, Prat M, Kerim S, Tamagnone L and Isidoro C:
Co-expression of plexin-B1 and Met in human breast and ovary
tumours enhances the risk of progression. Cell Oncol. 31:423–436.
2009.PubMed/NCBI
|
|
30
|
Gómez Román JJ, Garay GO, Saenz P,
Escuredo K, Sanz Ibayondo C, Gutkind S, Junquera C, Simón L,
Martínez A, Fernández Luna JL, et al: Plexin B1 is downregulated in
renal cell carcinomas and modulates cell growth. Transl Res.
151:134–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rody A, Holtrich U, Gaetje R, Gehrmann M,
Engels K, von Minckwitz G, Loibl S, Diallo-Danebrock R, Ruckhäberle
E, Metzler D, et al: Poor outcome in estrogen receptor-positive
breast cancers predicted by loss of plexin B1. Clin Cancer Res.
13:1115–1122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rody A, Karn T, Ruckhäberle E, Hanker L,
Metzler D, Müller V, Solbach C, Ahr A, Gätje R, Holtrich U, et al:
Loss of Plexin B1 is highly prognostic in low proliferating ER
positive breast cancers-results of a large scale microarray
analysis. Eur J Cancer. 45:405–413. 2009. View Article : Google Scholar
|
|
33
|
Zielonka M, Xia J, Friedel RH, Offermanns
S and Worzfeld T: A systematic expression analysis implicates
Plexin-B2 and its ligand Sema4C in the regulation of the vascular
and endocrine system. Exp Cell Res. 316:2477–2486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang WG, Douglas-Jones A and Mansel RE:
Levels of expression of lipoxygenases and cyclooxygenase-2 in human
breast cancer. Prostaglandins Leukot Essent Fatty Acids.
69:275–281. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Malik FA, Sanders AJ, Jones AD, Mansel RE
and Jiang WG: Transcriptional and translational modulation of KAI1
expression in ductal carcinoma of the breast and the prognostic
significance. Int J Mol Med. 23:273–278. 2009.PubMed/NCBI
|
|
36
|
Argast GM, Croy CH, Couts KL, Zhang Z,
Litman E, Chan DC and Ahn NG: Plexin B1 is repressed by oncogenic
B-Raf signaling and functions as a tumor suppressor in melanoma
cells. Oncogene. 28:2697–2709. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stevens L, McClelland L, Fricke A,
Williamson M, Kuo I and Scott G: Plexin B1 suppresses c-Met in
melanoma: A role for plexin B1 as a tumor-suppressor protein
through regulation of c-Met. J Invest Dermatol. 130:1636–1645.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Basile JR, Castilho RM, Williams VP and
Gutkind JS: Semaphorin 4D provides a link between axon guidance
processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA.
103:9017–9022. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ye SM, Han M, Kan CY, Yang LL, Yang J, Ma
QF and Wang SX: Expression and clinical significance of Sema4C in
esophageal cancer, gastric cancer and rectal cancer. Zhonghua Yi
Xue Za Zhi. 92:1954–1958. 2012.In Chinese. PubMed/NCBI
|
|
40
|
Pan GQ, Ren HZ, Zhang SF, Wang XM and Wen
JF: Expression of semaphorin 5A and its receptor plexin B3
contributes to invasion and metastasis of gastric carcinoma. World
J Gastroenterol. 15:2800–2804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Y, Zhang L, Pan Y, Ren X and Hao Q:
Over-expression of semaphorin4D, hypoxia-inducible factor-1α and
vascular endothelial growth factor is related to poor prognosis in
ovarian epithelial cancer. Int J Mol Sci. 13:13264–13274. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ein-Dor L, Kela I, Getz G, Givol D and
Domany E: Outcome signature genes in breast cancer: Is there a
unique set? Bioinformatics. 21:171–178. 2005. View Article : Google Scholar
|
|
43
|
van de Vijver MJ, He YD, van’t Veer LJ,
Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C,
Marton MJ, et al: A gene-expression signature as a predictor of
survival in breast cancer. N Engl J Med. 347:1999–2009. 2002.
View Article : Google Scholar : PubMed/NCBI
|
